13F HOLDINGS REPORT
VR Adviser, LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001415889-25-021914
Total Value
$1.33B
Positions
31
Other Managers
0
Confidential Omitted
No
Holdings (31)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | APGE | 8,493,321 | $368.9M | 27.64% |
| 2 | OCULAR THERAPEUTIX INC | OCUL | 12,762,462 | $118.4M | 8.88% |
| 3 | METSERA INC | 59267L107 | 3,750,662 | $106.7M | 8.00% |
| 4 | ENLIVEN THERAPEUTICS INC | ELVN | 4,026,331 | $80.8M | 6.05% |
| 5 | KALVISTA PHARMACEUTICALS INC | KALV | 6,728,985 | $76.1M | 5.70% |
| 6 | ORIC PHARMACEUTICALS INC | ORIC | 6,596,885 | $67.0M | 5.02% |
| 7 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,882,709 | $54.3M | 4.07% |
| 8 | ORUKA THERAPEUTICS INC | ORKA | 4,148,428 | $46.5M | 3.48% |
| 9 | SPYRE THERAPEUTICS INC | SYRE | 2,685,448 | $40.2M | 3.01% |
| 10 | PHARVARIS N V | PHVS | 2,047,620 | $36.0M | 2.70% |
| 11 | COGENT BIOSCIENCES INC | COGT | 4,755,411 | $34.1M | 2.56% |
| 12 | JADE BIOSCIENCES INC | JBIO | 3,220,364 | $32.2M | 2.41% |
| 13 | CYTOMX THERAPEUTICS INC | CTMX | 13,969,882 | $31.7M | 2.38% |
| 14 | CIDARA THERAPEUTICS INC | 171757206 | 639,088 | $31.1M | 2.33% |
| 15 | UPSTREAM BIO INC | UPB | 2,295,319 | $25.2M | 1.89% |
| 16 | ERASCA INC | ERAS | 17,857,083 | $22.7M | 1.70% |
| 17 | CRESCENT BIOPHARMA INC. | CBIO | 1,387,864 | $22.4M | 1.68% |
| 18 | DYNE THERAPEUTICS INC | DYN | 2,173,913 | $20.7M | 1.55% |
| 19 | SAVARA INC | SVRA | 8,884,263 | $20.3M | 1.52% |
| 20 | DIANTHUS THERAPEUTICS INC | DNTH | 1,000,000 | $18.6M | 1.40% |
| 21 | ENGENE HOLDINGS INC | ENGNW | 5,046,414 | $18.4M | 1.38% |
| 22 | ASTRIA THERAPEUTICS INC | 04635X102 | 2,457,348 | $13.2M | 0.99% |
| 23 | CULLINAN THERAPEUTICS INC | CGEM | 1,379,965 | $10.4M | 0.78% |
| 24 | ABIVAX SA | AAVXF | 1,345,780 | $10.3M | 0.77% |
| 25 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 750,000 | $8.0M | 0.60% |
| 26 | SEPTERNA INC | SEPN | 540,453 | $5.7M | 0.43% |
| 27 | SURROZEN INC | SRZNW | 632,931 | $5.7M | 0.42% |
| 28 | ZURA BIO LTD | ZURA | 4,631,216 | $4.9M | 0.36% |
| 29 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 1,609,569 | $2.4M | 0.18% |
| 30 | CASI PHARMACEUTICALS INC | CASIF | 987,259 | $1.2M | 0.09% |
| 31 | TENAX THERAPEUTICS INC | TENX | 98,564 | $567,729 | 0.04% |